• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE CR FEM LT SZ 9 CEM; ATTUNE IMPLANT : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE CR FEM LT SZ 9 CEM; ATTUNE IMPLANT : KNEE FEMORAL Back to Search Results
Model Number 1504-00-109
Medical Device Problem Code Loss of or Failure to Bond (1068)
Health Effect - Clinical Codes Edema (1820); Pain (1994); No Code Available (3191)
Date of Event 05/02/2015
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).Occupation: lawyer.(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Medical records received ad 25 nov 2019.Medical records received on 25 november 2019 were reviewed to identify patient harms/product issues on 16 december 2019.On (b)(6) 2015, the patient underwent total left knee arthroplasty due to degenerative joint disease.The patella was resurfaced.The surgeon reported no intraoperative complications.The patient was implanted with the attune knee system and unknown bone cement.On (b)(6) 2017, the patient underwent a left knee revision due to loosening of the tibial component, swelling and pain.The surgeon reported a patelloplasty was also performed with the removal of bone spurs.He noted the patellar component was well fixed and well positioned and was debrided.The surgeon reported a synovectomy of some tissue that was consistent with osteolysis.He indicated the femoral component appeared loose with motion and some areas did not retain much cement.The surgeon reported the tibial component had motion between the component medially ant the bone.Both the femoral and tibial components were revised, and the patellar component was retained.The patient was implanted with a competitor system and there were no complications to the procedure.Doi: (b)(6) 2015, dor: (b)(6) 2017 (lt knee).
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: corrected: h6.Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.A worldwide complaint database search found no other related reported incidents against the provided product code/lot number combination since release for distribution.Based on previous investigations, this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : null.Device history batch: null.Device history review: null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE CR FEM LT SZ 9 CEM
Common Device Name
ATTUNE IMPLANT : KNEE FEMORAL
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key9564173
Report Number1818910-2020-01022
Device Sequence Number2769016
Product Code JWH
UDI-Device Identifier10603295041108
UDI-Public10603295041108
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K101433
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2017
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 12/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Expiration Date12/31/2023
Device Model Number1504-00-109
Device Catalogue Number150400109
Device Lot Number473115
Initial Date Received by Manufacturer 12/16/2019
Supplement Date Received by Manufacturer02/04/2020
Initial Report FDA Received Date01/08/2020
Supplement Report FDA Received Date02/10/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
-
-